Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Grant or award SVP & Chief Financial Officer acquired 28,750 shares (grant or award)
  2. 4 Grant or award SVP Pharma Dev & Mfg Ops acquired 18,500 shares (grant or award)
  3. 4 Grant or award SVP & Chief Scientific Officer acquired 23,950 shares (grant or award)
  4. 4 Open-market sale SVP & Chief Accounting Officer sold 4,016 shares at $38.25 ($153,612)
  5. 4 Open-market sale President & CEO sold 15,326 shares at $38.25 ($586,220)
  6. 4 Open-market sale SVP & Chief Operating Officer sold 5,982 shares at $38.25 ($228,812)
  7. 4 Open-market sale SVP & Chief Financial Officer sold 6,515 shares at $38.25 ($249,199)
  8. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 4,694 shares at $38.25 ($179,546)
  9. 4 Open-market sale SVP & Chief Scientific Officer sold 4,524 shares at $38.25 ($173,043)
  10. 4 Grant or award SVP & Chief Accounting Officer acquired 90,000 shares (grant or award)
  11. 4 Grant or award Director acquired 4,750 shares (grant or award)
  12. 4 Grant or award Director acquired 4,750 shares (grant or award)
  13. 4 Grant or award Director acquired 4,750 shares (grant or award)
  14. 4 Grant or award Director acquired 4,750 shares (grant or award)
  15. 4 Grant or award Director acquired 4,750 shares (grant or award)
  16. 4 Grant or award Director acquired 4,750 shares (grant or award)
  17. 4 Grant or award Director acquired 8,500 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale Director sold 9,000 shares at $56.98 ($512,820)
  20. 4 Open-market sale Director sold 4,500 shares at $56.81 ($255,645)

Page 16 of 49 · 970 filings